Metabolic syndrome and migraine

Frontiers in Neurology

Volumn NOV, Issue , 2012, Pages

  Sachdev, Amit ^a   Marmura, Michael J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Hyperlipidemia; Hypertension; Inflammatory state; Insulin resistance; Metabolic syndrome; Migraine; Obesity; Prothrombotic state

Indexed keywords

EID: 84870894862     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2012.00161     Document Type: Article

References (135)

1. Adeney, K. L., and Williams, M. (2006). Migraine headaches and preeclampsia: an epidemiologic review. Headache 46, 794-803.
2. Aderjan, D., Stankewitz, A., and May, A. (2010). Neuronal mechanisms during repetitive trigemino-nociceptive stimulation in migraine patients. Pain 151,97-103.
3. Alberici, A., Borroni, B., Manelli, F., Griffini, S., Zavarise, P., Padovani, A., et al. (2009). Topiramate weight loss in migraine patients. J. Neurol. Sci. 278, 64-65.
4. Alberti, K. G., Zimmet, P., and Shaw, J. (2006). Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet. Med. 23, 469-480.
5. Allais, G., Gabellari, I., Borgogno, P., De Lorenzo, C., and Benedetto, C. (2010). The risks of women with migraine during pregnancy. Neurol. Sci. 31 (Suppl. 1),S59-S61.
6. Allais, G., Gabellari, I., Mana, O., Schiapparelli, P., Terzi, M. G., and Benedetto, C. (2008). Migraine and stroke: the role of oral contraceptives. Neurol. Sci. 29(Suppl. 1), S12-S14.
7. Alpay, K., Erta, M., Orhan, E. K., Ustay, D. K., Lieners, C., and Baykan, B. (2010). Diet restriction in migraine, based on IgG against foods: a clinical double-blind, randomised, crossover trial. Cephalalgia 30, 829-837.
8. Anscombe, R., Krebs, J., Weatherall, M., and Harding, S. A. (2006). Redefinition of the metabolic syndrome -useful or creating illness? N. Z. Med. J. 119,U2372.
9. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miya-gawa, J., et al. (1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257, 79-83.
10. Aschner, P. (2010). Metabolic syndrome as a risk factor for diabetes. Expert Rev. Cardiovasc. Ther. 8,407-412.
11. Asherson, R. A., Giampaulo, D., Singh, S., and Sulman, L. (2007). Dramatic response of severe headaches to anticoagulation in a patient with antiphospholipid syndrome. J. Clin. Rheumatol. 13, 173-174.
12. Aurora, S., Kori, S., Barrodale, P., Nelsen, A., and McDonald, S. (2007). Gastric stasis occurs in spontaneous, visually induced, and interictal migraine. Headache 47,1443-1446.
13. Aurora, S. K., Dodick, D., Turkel, C. C., DeGryse, R. E., Silberstein, S. D., Lipton, R. B., et al. (2010). OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 30, 793-803.
14. Ayata, C. (2010). Cortical spreading depression triggers migraine attack: pro. Headache 50, 725-730.
15. Ba'albaki, H., and Rapoport, A. (2008). Mast cells activate the renin angiotensin system and contribute to migraine: a hypothesis. Headache 1499-1505.
16. Barbanti, P., Aurilia, C., Egeo, G., and Fofi, L. (2010). Hypertension as a risk factor for migraine chronifica-tion. Neurol. Sci. 31 (Suppl. 1), S41-S43.
17. Bays, H. (2010). Phentermine, topiramate and their combination for the treatment of adiposopa-thy ('sick fat') and metabolic disease. Expert Rev. Cardiovasc. Ther. 8, 1777-1801.
18. Berilgen, M. S., Bulut, S., Gonen, M., Tekatas, A., Dag, E., and Mungen, B. (2005). Comparison of the effects of amitriptyline and flunarizine on weight gain and serum leptin, C pep-tide and insulin levels when used as migraine preventive treatment. Cephalalgia 25, 1048-1053.
19. Bhushan, B., Misra, A., and Guleria, R. (2010). Obstructive sleep apnea is independently associated with the metabolic syndrome in obese Asian Indians in northern India. Metab. Syndr. Relat. Disord. 8, 431-435.
20. Bickel, A., Kornhuber, J., Maihöfner, C., andRopohl,A. (2005). Exacerbation of migraine attacks during treatment with the selective serotonin reuptake inhibitor sertraline. A case report. Pharmacopsychiatry 38, 327-328.
21. Bigal, M. E. (2010). Migraine and cardiovascular disease. A call for action. Headache 50, 882-883.
22. Bigal, M. E., Gironda, M., Tepper, S. J., Feleppa, M., Rapoport, A. M., Sheftell, F. D., et al. (2006a). Headache prevention outcome and body mass index. Cephalalgia 26, 445-450.
23. Bigal, M. E., Liberman, J., and Lipton, R.B. (2006b). Obesity and migraine: a population study. Neurology 66, 545-550.
24. Bigal, M. E., and Lipton, R. (2006). Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 67, 252-257.
25. Bigal, M. E., Lipton, R., Biondi, D. M., Xiang, J., and Hulihan, J. (2009). Weight change and clinical markers of cardiovascular disease risk during preventive treatment of migraine. Cephalalgia 29, 1188-1196.
26. Bigal, M. E., Lipton, R., Holland, P. R., and Goadsby, P. J. (2007a). Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology 68,1851-1861.
27. Bigal, M. E., Tsang, A., Loder, E., Serrano, D., Reed, M. L., and Lipton, R. B. (2007b). Body mass index and episodic headaches: a population-based study. Arch. Intern. Med. 167, 1964-1970.
28. Bigal, M.E., Sheftell, F., Rapoport, A.M., Tepper, S. J., and Lipton, R. B. (2002). Chronic daily headache: identification of factors associated with induction and transformation. Headache 42,575-581.
29. Blau, J. N. (1992). Migraine: theories of pathogenesis. Lancet 339, 1202-1207.
30. Bond, D. S., Roth, J., Nash, J. M., and Wing, R. R. (2010). Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment. Obes. Rev. 12,e362-e371.
31. Bottini, F., Celle, M., Calevo, M. G., Amato, S., Minniti, G., Montaldi, L., et al. (2006). Metabolic and genetic risk factors for migraine in children. Cephalalgia 26, 731-737.
32. Buse, D. C., Manack, A., Serrano, D., Turkel, C., and Lipton, R. B. (2010). Sociodemographic and comorbid-ity profiles of chronic migraine and episodic migraine sufferers. J. Neurol. Neurosurg. Psychiatr. 81, 428-432.
33. Buzzi, M. G., and Tassorelli, C. (2010). Experimental models of migraine. Handb. Clin. Neurol. 97, 109-123.
34. Caproni, S., Corbelli, I., Pini, L. A., Cupini, M. L., Calabresi, P., and Sarchielli, P. (2011). Migraine preventive drug-induced weight gain maybe mediated by effects on hypo-thalamic peptides: the results of a pilot study. Cephalalgia 31,543-549.
35. Cavestro, C., Rosatello, A., Micca, G., Ravotto, M., Marino, M. P., Asteggiano, G., et al. (2007). Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine? Headache 47,1436-1442.
36. Cirillo, M., Stellato, D., Lombardi, C., De Santo, N. G., and Covelli, V. (1999). Headache and cardiovascular risk factors: positive association with hypertension. Headache 39,409-416.
37. Culpepper, L. (2010). Why do you need to move beyond first-line therapy for major depression? J. Clin. Psychiatry 71(Suppl. 1),4-9.
38. Curtain, R. (2006). No mutations detected in the INSR gene in a chromosome 19p 13 linked migraine pedigree. Eur. J. Med. Genet. 49, 57-62.
39. Dai, D. F., Hwang, J., Chen, C. L., Chiang, F. T., Lin, J. L., Hsu, K. L., et al. (2010). Effect of physical activity on the prevalence of metabolic syndrome and left ventricular hypertrophy in apparently healthy adults. J. Formos. Med. Assoc. 109, 716-724.
40. Damen, L., Bruijn, J., Koes, B. W., Berger, M. Y., Passchier, J., and Ver-hagen, A. P. (2006). Prophylactic treatment of migraine in children. Part 1. A systematic review of non-pharmacological trials. Cephalalgia 26, 373-383.
41. Dittrich, S. M., Gunther, V., Franz, G., Burtscher, M., Holzner, B., and Kopp, M. (2008). Aerobic exercise with relaxation: influence on pain and psychological well-being in female migraine patients. Clin. J. Sport Med. 18,363-365.
42. Dodick, D. W., Freitag, F., Banks, J., Saper, J., Xiang, J., Rupnow, M., et al. (2009). Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferior-ity trial in adult migraineurs. Clin. Ther. 31, 542-559.
43. Dowson, A., Mullen, M., Peatfield, R., Muir, K., Khan, A. A., Wells, C., et al. (2008). Migraine intervention with STARFlex technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 117, 1397-1404.
44. East, C., Willis, B., Barlow, C. E., Grannemann, B. D., FitzGerald, S. J., DeFina, L. F., et al. (2010). Depressive symptoms and metabolic syndrome in preventive healthcare: the Cooper Center longitudinal study. Metab. Syndr. Relat. Disord. 8, 451-457.
45. Eross, E., Dodrick, D., and Eross, M. (2007). The sinus, allergy and migraine study (SAMS). Headache 47,213-224.
46. Fonseca, V. A. (2010). Effects of beta-blockers on glucose and lipid metabolism. Curr. Med. Res. Opin. 26, 615-629.
47. Ford, E. S., Li, C., Pearson, W S., Zhao, G., Strine, T. W., and Mokdad, A. H. (2008). Body mass index and headaches: findings from a national sample of US adults. Cephalalgia 28, 1270-1276.
48. Franzoni, E., Verrotti, A., Sarajlija, J., Garone, C., Matricardi, S., Salerno, G. G., et al. (2007). Topiramate: effects on serum lipids and lipopro-teins levels in children. Eur. J. Neurol. 14,1334-1337.
49. Friedman, J. M. (2009). Obesity: causes and control of excess body fat. Nature 459, 340-342.
50. Funato, H., Tsai, A., Willie, J. T., Kisanuki, Y., Williams, S. C., and Sakurai, T. (2009). Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity. Cell Metab. 9, 64-76.
51. Gilman, D. K., Palermo, T., Kabbouche, M. A., Hershey, A. D., and Powers, S. W (2007). Primary headache and sleep disturbances in adolescents. Headache 47,1189-1194.
52. Gipponi, S., Venturelli, E., Rao, R., Liberini, P., and Padovani, A. (2010). Hypertension is a factor associated with chronic daily headache. Neurol. Sci. 31(Suppl. 1),S171-S173.
53. Gobel, H. (2004). Botulinum toxin in migraine prophylaxis. J. Neurol. 251(Suppl. 1), I8-I11.
54. Granella, F., Farina, S., Malferrari, G., and Manzoni, G. C. (1987). Drug abuse in chronic headache: a clinico-epidemiologic study. Cephalalgia 7, 15-19.
55. Gudmundsson, L. S., Thorgeirsson, G., Sigfusson, N., Sigvaldason, H., and Johannsson, M. (2006). Migraine patients have lower systolic but higher diastolic blood pressure compared with controls in a population-based study of 21,537 subjects. The Reykjavik study. Cephalalgia 26, 436-444.
56. Guldiken, B., Guldiken, S., Demir, M., Turgut, N., and Tugrul, A. (2008). Low leptin levels in migraine: a case control. Headache 48,1103-1107.
57. Guldiken, B., Guldiken, S., Taskiran, B., Koc, G., Turgut, N., Kabayel, L., et al. (2009). Migraine in metabolic syndrome. Neurologist 15, 55-58.
58. Gupta, A. K., Dahlof, B., Sever, P. S., Poulter, N. R. and Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm Investigators. (2010). Metabolic syndrome, independent of its components, is a risk factor for stroke and death but not for coronary heart disease among hypertensive patients in the ASCOT-BPLA. Diabetes Care 33, 1647-1651.
59. Hansen, D., Dendale, P., van Loon, L. J., and Meeusen, R. (2010). The impact of training modalities on the clinical benefits of exercise intervention in patients with cardiovascular disease risk or type 2 diabetes mellitus. Sports Med. 40, 921-940.
60. Harrison, C. L., Ferrier, N., and Young, A. H. (2004). Tolerabil-ity of high-dose venlafaxine in depressed patients. J. Psychopharma-col. (Oxford) 18, 200-204.
61. Hauge, A. W., Kirchmann, M., and Ole-sen, J. (2010). Characterization of consistent triggers of migraine with aura. Cephalalgia 31, 416-438.
62. Herak, D. C., Antolic, M., Krleza, J. L., Pavic, M., Dodig, S., Duranovic, V., et al. (2009). Inherited prothrom-botic risk factors in children with stroke, transient ischemic attack, or migraine. Pediatrics 123,e653-e660.
63. Heuch, I., Hagen, K., Heuch, I., Nygaard, O., and Zwart, J. A. (2010). The impact of body mass index on the prevalence of low back pain: the HUNT study. Spine 35, 764-768.
64. Holland, P. R., Akerman, S., and Goadsby,P. J. (2005). Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular noci-ception. J. Pharmacol. Exp. Ther. 5, 1380-1385.
65. Horev, A., Wirguin, I., Lantsberg,L., and Ifergane, G. A. (2005). A high incidence of migraine with aura among morbidly obese women. Headache 45, 936-938.
66. Hosseini, M., Alaei, H., Naderi, A., Sharifi, M. R., and Zahed, R. (2009). Treadmill exercise reduces self-administration of morphine in male rats. Pathophysiology 16, 3-7.
67. Jang, M. U., Park, J., Kho, H. S., Chung, S. C., and Chung, J. W. (2010). Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients. Oral. Dis. 17, 187-193.
68. Kahn, R., Buse, J., Ferrannini, E., and Stern, M. (2005). The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28, 2289-2304.
69. Katsnelson, M. J., Peterlin, B., Rosso, A. L., Alexander, G. M., and Erwin, K. L. (2009). Self-reported vs measured body mass indices in migraineurs. Headache 49, 663-668.
70. Kaunisto, M. A., Tikka, P., Kallela, M., Leal, S. M., Papp, J. C., Korhonen, A., etal. (2005). Chromosome 19p13 loci in Finnish migraine with aura families. Am. J. Med. Genet. B Neu-ropsychiatr. Genet. 132B, 85-89.
71. Keith, S. W., Wang, C., Fontaine, K. R., Cowan, C. D., and Allison, D. B. (2008). BMI and headache among women: results from 11 epidemiologic datasets. Obesity 16, 377-383.
72. Koçer, A., Dikici, S., Atakay, S., and Okuyucu, S. (2008). Serum uric acid and lipid levels while taking topiramate for migraine. Headache 48,1056-1060.
73. Kopelman, P. G. (2000). Obesity as a medical problem. Nature 404, 635-643.
74. Köseoglu, E., Akboyraz, A., Soyuer, A., and Ersoy, A. O. (2003). Aerobic exercise and plasma beta endorphin levels in patients with migrainous headache without aura. Cephalalgia 23, 972-976.
75. Kowacs, P. A., Piovesan, E., and Tep-per, S. J. (2009). Rejection and acceptance of possible side effects of migraine prophylactic drugs. Headache 49, 1022-1027.
76. Kruit, M. C., Van Buchem, M., Launer, L. J., Terwindt, G. M., and Ferrari, M. D. (2010). Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia 30, 129-136.
77. Kurth, T., Gaziano, J., Cook, N. R., Logroscino, G., Diener, H. C., and Buring, J. E. (2006). Migraine and risk of cardiovascular disease in women. JAMA 296,283-291.
78. Lockett, D. M., and Campbell, J. F. (1992). The effects of aerobic exercise on migraine. Headache 32, 50-54.
79. Mäntyselkä, P., Kautianinen, H., and Vanhala, M. (2010). Prevalence of neck pain in subjects with metabolic syndrome - a cross-sectional population-based study. BMC Musculoskelet. Disord. 11, 171. doi:10.1186/1471-2474-11-171
80. Marino, E., Fanny, B., Lorenzi, C., Pirovano, A., Franchini, L., Colombo, C., et al. (2010). Genetic bases of comorbidity between mood disorders and migraine: possible role of serotonin transporter gene. Neurol. Sci. 31,387-391.
81. Marmura, M. J. (2009). Systemic abnormalities in migraine: what comes first. Neurologist 15, 53-54.
82. Mattsson, P. (2007). Migraine headache and obesity in women aged 40-74 years: a population-based study. Cephalalgia 27, 877-880.
83. McCarthy, L. C., Hosford, D., Riley, J. H., Bird, M. I., White, N. J., Hewett, D. R., et al. (2001). Single-nucleotide polymorphism alleles in the insulin receptor gene are associ-atedwith typical migraine. Genomics 78, 135-149.
84. Melek, I. M., Seyfeli, E., Duru, M., Duman, T., Akgul, F., and Yalcin, F. (2007). Autonomic dysfunction and cardiac repolarization abnormalities in patients with migraine attacks. Med. Sci. Monit. 13, RA47-RA49.
85. Milde-Busch, A., Blaschek, A., Borggräfe, I., Heinen, F., Straube, A., and von Kries, R. (2010). Associations of diet and lifestyle with headache in high-school students: results from a cross-sectional study. Headache 50, 1104-1114.
86. Milner, P. M. (1958). Note on a possible correspondence between the scotomas of migraine and spreading depression of Leão. Electroen-cephalogr. Clin. Neurophysiol. 10, 705.
87. Moja, P. L., Cusi, C., Sterzi, R. R., and Canepari, C. (2005). Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst. Rev. 20, CD002919.
88. Molarius, A., Tegelberg,A., and Ohrvik, J. (2008). Socio-economic factors, lifestyle, and headache disorders - a population-based study in Sweden. Headache 48, 1426-1437.
89. Moschiano, F., D'Amico, A. D., Di Ste-fano, M., Rocca, N., and Bussone, G. (2007). The role of the clinician in interpreting conventional neuroimaging findings in migraine patients. Neurol. Sci. 28(Suppl.), S114-S117.
90. Mottillo, S., Filion, K., Genest, J., Joseph, L., Pilote, L., Poirier, P., et al. (2010). The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J. Am. Coll. Car-diol. 56, 1113-1132.
91. Mueller, L., Gupta, A., and Stein, T. P. (2001). Deficiency of tumor necrosis factor alpha in a subclass of menstrual migraineurs. Headache 41, 129-137.
92. Netzer, C., Freudenberg, J., Heinze, A., Heinze-Kuhn, K., Goebel, I., McCarthy, L., et al. (2008). Replication study of the insulin receptor gene in migraine with aura. Genomics 91, 503-507.
93. Okifuji, A., Donaldson, G., Barck, L., and Fine, P. G. (2010). Relationship between fibromyalgia and obesity in pain, function, mood, and sleep. J. Pain 11, 1329-1337.
94. Peterlin, B. L. (2009). The role of the adipocytokines adiponectin and leptin in migraine. J. Am. Osteopath. Assoc. 109,314-317.
95. Peterlin, B. L., Bigal, M., Tepper, S. J., Urakaze, M., Sheftell, F. D., and Rapoport, A. M. (2007). Migraine and adiponectin: is there a connection? Cephalalgia 27,435-446.
96. Peterlin, B. L., Rosso, A., Rapoport, A. M., and Scher, A. I. (2010). Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache 50, 52-62.
97. Pinhas-Hamiel, O., Frumin, K., Gabis, L., Mazor-Aronovich, K., Modan-Moses, D., Reichman, B., et al. (2008). Headaches in overweight children and adolescents referred to a tertiary-care center in Israel. Obesity 16,659-663.
98. Pylvänen, V., Knip, M., Pakarinen, A., Kotila, M., Turkka, J., and Iso-järvi, J. I. (2002). Serum insulin and leptin levels in valproate-associated obesity. Epilepsia 43, 514-517.
99. Rainero, I., Limone, P., Ferrero, M., Val-frè, W., Pelissetto, C., Rubino, E., et al. (2005). Insulin sensitivity is impaired in patients with migraine. Cephalalgia 25, 593-597.
100. Rains, J. C. (2008). Chronic headache and potentially modifiable risk factors: screening and behavioral management of sleep disorders. Headache 48, 32-39.
101. Rains, J. C., and Poceta, J. (2006). Headache and sleep disorders: review and clinical implications for headache management. Headache 46,1344-1363.
102. Rains, J. C., and Poceta, J. (2010). Sleep and headache. Curr. Treat. Options Neurol. 12, 1-15.
103. Ray, L., Lipton, R., Zimmerman, M. E., Katz, M. J., and Derby, C. A. (2010). Mechanisms of association between obesity and chronic pain in the elderly. Pain 152, 53-59.
104. Ray, S. T., and Kumar, R. (2010). Migraine and obesity: cause or effect. Headache 50, 326-327.
105. Recober, A., and Goadsby, P. (2010). Calcitonin gene-related peptide: a molecular link between obesity and migraine? Drug News Perspect. 23, 112-117.
106. Rigatelli, G., Cardaioli, P., Dell'avvocata, F., Giordan, M., Nanjundappa, A., Mandapaka, S., et al. (2010). May migraine post-patent foramen ovale closure sustain the microembolic genesis of cortical spread depression? Cardiovasc. Revasc. Med. 12, 217-219.
107. Robberstad, L., Dyb, G., Hagen, K., Stovner, L. J., Holmen, T. L., and Zwart, J. A. (2010). An unfavorable lifestyle and recurrent headaches among adolescents: the HUNT study. Neurology 75, 712-717.
108. Rönnemaa, T., Pulkki, K., and Kaprio, J. (2000). Serum soluble tumor necrosis factor-alpha receptor 2 is elevated in obesity but is not related to insulin sensitivity: a study in identical twins discordant for obesity. J. Clin. Endocrinol. Metab. 85, 2728-2732.
109. Rozen, T., and Swidan, S. (2007). Elevation of CSF tumor necrosis factor alpha levels in new daily persistent headache and treatment refractory chronic migraine. Headache 47, 1050-1055.
110. Scher, A. I., Stewart, W., Ricci, J. A., and Lipton, R. B. (2003). Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106, 81-89.
111. Schütt, M., Brinkhoff, J., Drenckhan, M., Lehnert, H., Sommer, C. (2010). Weight reducing and metabolic effects of topiramate in patients with migraine - an observational study. Exp. Clin. Endocrinol. Diabetes 118, 449-452.
112. Seçil, Y., Unde, C., Beckmann, Y. Y., Bozkaya, Y T., Ozerkan, F., and Basoglu, M. (2010). Blood pressure changes in migraine patients before, during and after migraine attacks. Pain Pract. 10, 222-227.
113. Sharma, A., Pischon, T., Hardt, S., Kunz, I., and Luft, E C. (2001). Hypothesis: β-adrenergic receptor blockers and weight gain a systematic analysis. Hypertension 37, 250-254.
114. Stofkova, A. (2009). Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr. Regul. 43, 157-168.
115. Strelniker, Y. M. (2009). Intensive running completely removes a migraine attack. Med. Hypotheses 72, 608.
116. Su, C. F., Chang, Y., Pai, H. H., Liu, I. M., Lo, C. Y., and Cheng, J. T. (2005). Mediation of beta-endorphin in exercise-induced improvement in insulin resistance in obese Zucker rats. Diabetes Metab. Res. Rev. 21, 175-182.
117. Summ, O., Charbit, A., Andreou, A. P., and Goadsby, P. J. (2010). Modulation of nociceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus. Brain 133, 2540-2548.
118. Sun-Edelstein, C., and Mauskop, A. (2009). Foods and supplements in the management of migraine headaches. Clin. J. Pain 25, 446-452.
119. Taylor, E R. (2008). Weight change associated with the use of migraine-preventive medications. Clin. Ther. 30,1069-1080.
120. Tellez-Zenteno, J., Pahwa, D., Hernandez-Ronquillo, L., Garcia-Ramos, G., and Velazquez, A. (2010). Association between body mass index and migraine. Eur. Neurol. 64, 134-139.
121. Tietjen, G. E., Peterlin, B., Brandes, J. L., Hafeez, F., Hutchinson, S., Martin, V. T., et al. (2007). Depression and anxiety: effect on the migraine-obesity relationship. Headache 47, 866-875.
122. Tokgoz, H., Aydin, K., Oran, B., and Kiyici, A. (2012). Plasma leptin, neuropeptide Y, ghrelin, and adiponectin levels and carotid artery intima media thickness in epileptic children treated with valproate. ChildsNerv. Syst. 28,1049-1053.
123. Touati, S., Meziri, F., Devaux, S., Berth-elot, A., Touyz, R. M., and Laurant, P. (2010). Exercise reverses metabolic syndrome in high fat diet-induced obese rats. Med. Sci. Sports Exerc. 43, 398-407.
124. Trabattoni, D., Fabbiocchi, F., Montorsi, P., Galli, S., Teruzzi, G., Grancini, L., et al. (2011). Sustained long-term benefit of patent foramen ovale closure on migraine. Catheter Cardiovasc. Interv. 77, 570-574.
125. Valenzuela, R. F., Donoso, M., Mel-lado, P. A., and Huidobro-Toro, J. P. (2000). Migraine, but not sub-arachnoid hemorrhage, is associated with differentially increased NPY-like immunoreactivity in the CSF. J. Neurol. Sci. 173, 140-146.
126. Van Den Maagdenberg, A. M., Terwindt, G., Haan, J., Frants, R. R., and Ferrari, M. D. (2010). Genetics of headaches. Handb. Clin. Neurol. 97, 85-97.
127. Varkey, E., Cider, A., Carlsson, J., and Linde,M. (2009).Astudyto evaluate the feasibility of an aerobic exercise program in patients with migraine. Headache 49, 563-570.
128. Varkey, E., Hagen, K., Zwart, J. A., and Linde, M. (2008). Physical activity and headache: results from the Nord-Trøndelag health study (HUNT). Cephalalgia 28, 1292-1297.
129. Viola, S., Viola, P., Litterio, P., Buon-garzone, M. P., and Fiorelli, L. (2010). Pathophysiology of migraine attack with prolonged aura revealed by transcranial Doppler and near infrared spectroscopy. Neurol. Sci. 31,S165-S166.
130. Wilmshurst, P. T., Nightingale, S., Walsh, K. P., and Morrison, W L. (2005). Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart 91, 1173-1175.
131. Winter, A. C., Berger, K., Buring, J. E., and Kurth, T. (2009). Body mass index, migraine, migraine frequency and migraine features in women. Cephalalgia 29,269-278.
132. Yadav, R. K., Kalita, J., and Misra, U. K. (2010). A study of triggers of migraine in India. Pain Med. 11, 44-47.
133. Yilmaz, I. A., Ozge, A., Erdal, M. E., Edgünlü, T. G., Cakmak, S. E., and Yalin, O. O. (2010). Cytokine polymorphism in patients with migraine: some suggestive clues of migraine and inflammation. Pain Med. 11, 492-497.
134. Young, W B. (2008). Prevention treatment of migraine: effect on weight. Curr. Pain Headache Rep. 12, 201-206.
135. Young, W B., and Rozen, T. (2005). Preventive treatment of migraine: effect on weight. Cephalalgia 25,1-11.